Oncolytics Biotech Inc (ONCY): Net Income

Annual figures by period end, from SEC filings.

-$28.76M

Year ended 2025-12-31

-$37.46M

Trailing 12 months to 2026-06-30

2024-12-31 Net Income (USD) 2025-12-31

Period ended	Net Income	Change YoY	Source filing
2025-12-31	-$28.76M	n/m	2026-03-30, From 2025-01-01
2024-12-31	-$22.79M	n/a	2026-03-30, From 2024-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
Oncolytics Biotech Inc (ONCY)	2025-12-31	-$28.76M	n/m
Rocket One Inc. (RKTO)	2025-12-31	-$12.47M	n/m
Silo Pharma, Inc. (SILO)	2025-12-31	-$4.23M	n/m
Acurx Pharmaceuticals, Inc. (ACXP)	2025-12-31	-$7.97M	n/m
Ensysce Biosciences, Inc. (ENSC)	2025-12-31	-$10.18M	n/m
Processa Pharmaceuticals, Inc. (PCSA)	2025-12-31	-$13.56M	n/m
Telomir Pharmaceuticals, Inc. (TELO)	2025-12-31	-$10.41M	n/m
Dermata Therapeutics, Inc. (DRMA)	2025-12-31	-$7.56M	n/m
Matinas BioPharma Holdings, Inc. (MTNB)	2025-12-31	-$10.35M	n/m

Compare ONCY, RKTO, SILO, ACXP side by side · Screen every company in Pharmaceutical Preparations ↗